Bora Pharmaceuticals Co., LTD. (6472.TW)

TWD 679.0

(0.0%)

Long Term Debt Summary of Bora Pharmaceuticals Co., LTD.

  • Bora Pharmaceuticals Co., LTD.'s latest annual long term debt in 2023 was 3.48 Billion TWD , down -24.75% from previous year.
  • Bora Pharmaceuticals Co., LTD.'s latest quarterly long term debt in 2024 Q1 was 4.32 Billion TWD , up 31.66% from previous quarter.
  • Bora Pharmaceuticals Co., LTD. reported annual long term debt of 4.63 Billion TWD in 2022, up 247.34% from previous year.
  • Bora Pharmaceuticals Co., LTD. reported annual long term debt of 1.33 Billion TWD in 2021, down -10.06% from previous year.
  • Bora Pharmaceuticals Co., LTD. reported quarterly long term debt of 9.44 Billion TWD for 2024 Q2, up 142.12% from previous quarter.
  • Bora Pharmaceuticals Co., LTD. reported quarterly long term debt of 3.48 Billion TWD for 2023 Q4, down -2.9% from previous quarter.

Annual Long Term Debt Chart of Bora Pharmaceuticals Co., LTD. (2023 - 2019)

Historical Annual Long Term Debt of Bora Pharmaceuticals Co., LTD. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 3.48 Billion TWD -24.75%
2022 4.63 Billion TWD 247.34%
2021 1.33 Billion TWD -10.06%
2020 1.48 Billion TWD 33.74%
2019 1.1 Billion TWD 0.0%

Peer Long Term Debt Comparison of Bora Pharmaceuticals Co., LTD.

Name Long Term Debt Long Term Debt Difference
Grape King Bio Ltd 136.36 Million TWD -2457.168%
Standard Chem & Pharm CO., LTD. 222.97 Million TWD -1463.846%
Maywufa Company Ltd. 438.97 Million TWD -694.336%
ScinoPharm Taiwan, Ltd. 570.23 Million TWD -511.498%
Lotus Pharmaceutical Co., Ltd. 9.51 Billion TWD 63.37%
LIWANLI Innovation Co., Ltd. 361 Thousand TWD -965815.235%
YungShin Global Holding Corporation 241.99 Million TWD -1340.914%
PhytoHealth Corporation 17.46 Million TWD -19871.1%
SCI Pharmtech, Inc. 845.52 Million TWD -312.4%
Formosa Laboratories, Inc. 2.03 Billion TWD -71.106%
PharmaEssentia Corporation 954.99 Million TWD -265.127%